Tickerplace logo

Tickerplace

BioCryst Pharmaceuticals, Inc. logo

BCRXBioCryst Pharmaceuticals, Inc.

BCRX Stock Price, Valuation & Chart | BioCryst Pharmaceuticals, Inc.

Compare
$10.170+0.25 (+2.52%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyBCRX intrinsic valueBCRX calculated fair value vs price
OverviewFinancialsDividendsRatios

BCRX Historical price chart

BCRX Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization2.58B
PE Ratio-6.78
EPS-1.5
Trading Volume3.07M
Today's High/Low10.23/9.83
Dividend Yield0.00
52 Week High/Low11.22/6.0
Shares Outstanding254.16M
BCRX Financial Statement
BCRX Analyst ratings
BCRX Analysis & performance metrics

BCRX Company profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous…

BCRX Management team

Management
Yarlagadda S. Babu Ph.D.
Chief Discovery Officer
Philip George
Chief Strategy Officer
Alane P. Barnes
Senior Vice President, Chief Legal Officer & Corporate Secretary
Charles K. Gayer
Senior Vice President & Chief Commercial Officer
Jinky Ang Rosselli
Chief Data & Insights Officer
John D. Bluth
Chief Communications Officer
Stephanie Angelini
Chief People Officer
William P. Sheridan MBBS
Chief Development Officer
Total 8 executives

BCRX Frequently asked questions

What is BioCryst Pharmaceuticals, Inc. (BCRX) Stock Price?

Current stock price of BioCryst Pharmaceuticals, Inc. (BCRX) stock is $10.170. The stock price is +2.52% higher in the session. The intraday range can be seen from this page. Volume of BioCryst Pharmaceuticals, Inc. (BCRX) stock is 3.07M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the BioCryst Pharmaceuticals, Inc. (BCRX) stock price going up or down today?

The stock price of BioCryst Pharmaceuticals, Inc. (BCRX) can change with earnings, company news, and overall market sentiment. BioCryst Pharmaceuticals, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BioCryst Pharmaceuticals, Inc. stock expensive at its current price?

Whether BioCryst Pharmaceuticals, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BCRX on this page is -6.78. EPS on this page is -1.50. Compare those figures with peers and growth expectations before deciding if the current BioCryst Pharmaceuticals, Inc. price is justified.

How has the stock price of BioCryst Pharmaceuticals, Inc. (BCRX) performed historically?

Historical performance for BioCryst Pharmaceuticals, Inc. (BCRX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BCRX reacted to past earnings and market events.

Should I buy BioCryst Pharmaceuticals, Inc. (BCRX) stock, at this price?

Buying BioCryst Pharmaceuticals, Inc. (BCRX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.